Insights

Patented Cannabinoids Oscity BioSciences holds two granted U.S. patents on co-crystal solid forms of THC and broader coverage across CBN, CBG, CBDV and other cannabinoids, indicating strong IP protection and potential licensing opportunities for drug development programs seeking stable, bioavailable cannabinoid APIs.

cGMP Manufacturing With a cGMP certified facility in Foley, Alabama, Oscity can supply pharmaceutical-grade cannabinoid APIs and compliant hemp-derived raw materials at scale, presenting a reliable supply partner for researchers and contract manufacturers pursuing cannabinoid-based formulations.

Therapeutic Focus The company targets pain, epilepsy, inflammation, sleep, autoimmune and neuromuscular conditions, mood disorders, and neuroprotection, suggesting cross-domain applicability for collaborations, co-development ventures, and licensing of their co-crystal IP for diverse drug discovery programs.

IP License Potential Oscity’s proprietary extraction process and exclusive co-crystal IP offer a clear pathway for licensing discussions with pharmaceutical researchers and biotech groups aiming to improve stability, solubility, and bioavailability of cannabinoid therapies.

Early Stage Growth As a smaller biotech with revenue in the low seven figures and Alabama’s largest science-based biopharma manufacturer in hemp, Oscity presents a high-potential partner for strategic collaborations, contract development, and supply agreements to scale their innovative co-crystal technology.

Similar companies to Oscity BioSciences

Oscity BioSciences Tech Stack

Oscity BioSciences uses 8 technology products and services including Hotjar, HubSpot Analytics, iCIMS, and more. Explore Oscity BioSciences's tech stack below.

Oscity BioSciences's Email Address Formats

Oscity BioSciences uses at least 3 email formats:
Oscity BioSciences Email FormatsExamplePercentage
First@oscity.comJohn@oscity.com
86%
First.Last@oscity.comJohn.Doe@oscity.com
9%
FirstLas@oscity.comJohnDoe@oscity.com
5%

Frequently Asked Questions

What is Oscity BioSciences's official website and social media links?

Minus sign iconPlus sign icon
Oscity BioSciences's official website is oscitybioscience.com and has social profiles on LinkedIn.

How much revenue does Oscity BioSciences generate?

Minus sign iconPlus sign icon
As of September 2026, Oscity BioSciences's annual revenue is estimated to be $1M - $10M.

What is Oscity BioSciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Oscity BioSciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Oscity BioSciences have currently?

Minus sign iconPlus sign icon
As of September 2026, Oscity BioSciences has approximately 22 employees across 1 continents, including North America. Key team members include Farm Operations Director: S. M. Explore Oscity BioSciences's employee directory with LeadIQ.

What industry does Oscity BioSciences belong to?

Minus sign iconPlus sign icon
Oscity BioSciences operates in the Biotechnology Research industry.

What technology does Oscity BioSciences use?

Minus sign iconPlus sign icon
Oscity BioSciences's tech stack includes Hotjar, HubSpot Analytics, iCIMS, WordPress, Simpli.fi, PayPal, Venmo and Piwik PRO Core.

What is Oscity BioSciences's email format?

Minus sign iconPlus sign icon
Oscity BioSciences's email format typically follows the pattern of First@oscity.com. Find more Oscity BioSciences email formats with LeadIQ.

When was Oscity BioSciences founded?

Minus sign iconPlus sign icon
Oscity BioSciences was founded in 2020.
Oscity BioSciences logo

Oscity BioSciences

Biotechnology ResearchAlabama, United States11-50 Employees

Oscity BioSciences is a biotechnology research company focused on advancing cannabinoid-derived medications by leveraging a proprietary extraction process to produce high-purity co-crystals. Operating from an FDA-certified cGMP facility in Foley, Alabama, the firm emphasizes stability, solubility, and consistent bioavailability to support research and development across pain, epilepsy, inflammation, autoimmune and neuromuscular conditions, mood disorders, and neuroprotection. The company holds two U.S. patents covering co-crystal solid forms of THC, with an expanded portfolio across other cannabinoids, positioning it as a pioneer in crystalline solid-form technology within the cannabinoid space. Based in Alabama, Oscity describes itself as a biopharmaceutical manufacturing entity specializing in industrial hemp and related cannabinoid research. A recent development noted is the continued progression of its patented co-crystal IP and associated research capabilities at its Alabama facility.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Oscity BioSciences's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.